Shippeo Extends Paperless Transportation and Advanced Pallet Scanning Capabilities to Its Real-Time Visibility Platform
7.7.2020 15:18:00 EEST | Business Wire | Press release
Shippeo, the European leader in real-time transportation visibility solutions, has announced a new mobile application, offering a range of new capabilities. Shippeo’s mobile application allows truck drivers to manage electronic Bill of Lading via smartphone quickly and easily, unlocking the benefits of paperless administration. These include instant synchronisation with TMS for faster billing while also reducing administrative cost. In addition, electronic forms avoid paper handling, reducing hygiene concerns amid the Covid-19 pandemic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200707005487/en/
Shippeo mobile application (Photo: Shippeo)
The new Shippeo mobile application features include:
- Paperless proof of delivery for last mile
The mobile app integrates the generation of electronic Bills of Lading (or eCMRs) capturing electronic signatures and enabling paperless proof of delivery and fasting invoicing. Delivery personnel can quickly report on delivery completion, whether it was done OTIF (on time, in full) and complied with protocols, with the ability to take a photo of the item upon delivery. This data is synchronized with the platform in real-time, giving customer support teams instant access and triggering proactive alerts and notifications on delivery status automatically sent to customers.
- Unique and granular traceability from truck to unit-level
The application allows precise tracking of LTL loads, granting visibility down to the logistics unit level, capturing all key movements of a shipment throughout the delivery journey. The app comes with many standard pallet types prepopulated, with other unit sizes being customizable, from packages through to extra-large custom-sized shipments.
- SSCC pallet scanning for improved locating of returnable packaging
The ability to scan a pallet’s unique SSCC code via the mobile application also makes it easier to recover lost pallets, saving shippers and carriers the cost of replacements, by showing the pallet’s last known location.
- Dynamic milk-run synchronization
It also displays tour information, helping to organize milk runs and LTL loads. Any changes made to milk-runs by operational teams in their TMS are automatically and instantly synchronized with the app, increasing operational agility.
“Our incredible product team is working on a strong pipeline of product enhancements, as we listen closely to our customers’ evolving needs” says Lucien Besse, Chief Operating Officer at Shippeo. “Our aim is for the platform to surpass their expectations and exceed ROI goals as they leverage improved visibility to source greater value from their supply chain transport operations.”
More information: here
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005487/en/
Contact information
Press:
Céline Bonniot, celine.bonniot@shippeo.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Advances Operational Orchestration Vision with Agentic AI at Kinexions EMEA 202615.9.2026 14:00:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in AI-powered supply chain planning and orchestration, will bring together some of the world’s most innovative supply chain leaders at Kinexions EMEA 2026 from October 26-28. Building on the operational orchestration vision Kinaxis introduced earlier this year, the conference offers an inside look at how leading organizations are harnessing AI innovation and agentic capabilities to help supply chain leaders make better decisions, coordinate action across the business and drive measurable outcomes. From AI Potential to Operational Impact As organizations continue to invest heavily in AI, many struggle to translate intelligence into action - just 12% of supply chain leaders consider themselves AI leaders, despite widespread deployment of AI capabilities. Kinaxis CEO Razat Gaurav and Executive Vice President, EMEA, Fabienne Cêtre, will open the mainstage with an exploration of the market forces reshaping global supply chains and how operational orc
Cebreo Medical Receives CE Mark for NeuroBuds®, a Discreet In-Ear, Medical-Grade EEG Wearable for Extended Ambulatory Monitoring15.9.2026 14:00:00 EEST | Press release
Cebreo Medical today announced that its NeuroBuds® device has received CE marking, confirming conformity with applicable EU requirements. Unlike conventional EEG systems that require a technician-applied cap of electrodes, NeuroBuds is designed to be used unassisted by the patient at home, enabling multi-day and multi-night recordings in a patient's daily life environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914704547/en/ NeuroBuds(TM), EarEEG “With NeuroBuds, we can offer a discreet, unobtrusive solution that enables long-term, unassisted EEG monitoring for weeks, in patients’ own homes. The product has the potential to significantly reduce the cost of long-term EEG monitoring and strengthen treatment decisions compared with conventional brain monitoring.” — Rasmus Madsen, CEO, Cebreo Medical Designed to resemble a hearing aid, NeuroBuds is built to minimize the stigma and burden that typically limit complianc
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 202615.9.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression and is designed to help navigate care pathways for patients and providers. Change the Tune in TRD was developed to provide evidence-based education to U.S. HCPs on the longer, more persistent episodes associated with TRD, alongside cognitive and emotional patterns, including getting stuck in negative or repetitive ways of thinking, difficulty shifting perspective or navigating emotions, and feeling disconnected from pleasure or motivation1-8. While TRD originates as MDD, its burden and resistance to standard treatments distinguish it as a more complex condition. Compared to MDD, TRD patients experience almost 3x long
NIQ Launches Digital Purchase GeoAudiences Across Europe15.9.2026 13:00:00 EEST | Press release
NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including travel, automotive, technology, telecommunications and financial services. The launch expands NIQ’s GeoPurchase offering, which currently provides syndicated audiences across 13 international markets. Digital Purchase GeoAudiences address growing demand from advertisers for purchase-informed audience intelligence across a broader range of digital-first industries and shopping environments. By combining NIQ’s digital commerce intelligence with its GeoPurchase framework, the solution helps advertisers identify geographic areas showing stronger digital shopping activity. Marketers can use these signals to inform where they plan and prioritize media investment. “Marketers shouldn’t have to guess where demand is coming from before they invest,
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases15.9.2026 13:00:00 EEST | Press release
QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS). Lilly and QurCan will collaborate on multiple research programs focused on the development of PLNP-enabled genetic medicine therapeutics for CNS and PNS delivery. Through this collaboration, QurCan will be responsible for optimizing genetic medicine therapeutics using its TERP platform, and Lilly will be responsible for further research, clinical development, and commercialization of the selected programs. “This collaboration with Lilly represents a validation of our PLNP technology platform and its potential to address some of the most challenging delivery problems
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom